GPR65 therapy (OMass Therapeutics)

N/A

Report date: 2024/09/14 11:38:28
NME

Base Information

Drug NameGPR65 therapy (OMass Therapeutics)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionG-protein coupled receptor 65 inhibitors
TargetsG-protein coupled receptor 65
Therapy Area/IndicationsInflammatory Bowel Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOMass Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesGenentech IncOMass Therapeutics Ltd
Inactive CompaniesN/A
Active IndicationsInflammatory Bowel Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A